ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Global X China Biotech Innovation ETF
6.64
0.0000
成交量:
- -
成交额:
- -
市值:
139.44万
市盈率:
- -
高:
6.64
开:
6.64
低:
6.64
收:
6.64
52周最高:
6.64
52周最低:
6.64
股本:
21.00万
流通股本:
21.00万
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻
公告
抗体浪潮风起,这家Biotech紧抓机遇
药智网
·
08/17
股海导航_2025年6月16日_沪深股市公告与交易提示
市场资讯
·
06/16
6月16日上市公司重要公告集锦:博众精工拟4.2亿元收购上海沃典70%股权
证券日报
·
06/15
2025年6月16日涨停板早知道:七大利好有望发酵
市场资讯
·
06/15
晚间公告丨6月15日这些公告有看头
第一财经
·
06/15
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/CHB/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CHB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CHB\",,,,,undefined,":{"symbol":"CHB","market":"US","secType":"STK","nameCN":"Global X China Biotech Innovation ETF","latestPrice":6.64,"timestamp":1739998800000,"preClose":6.64,"halted":0,"volume":0,"delay":0,"floatShares":210000,"shares":210000,"eps":0,"marketStatus":"已收盘","change":0,"latestTime":"02-19 16:00:00 EST","open":6.64,"high":6.64,"low":6.64,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1755849600000},"marketStatusCode":5,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":6.64,"sharesOutstanding":210000,"nav":6.72,"aum":1412042.9,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CHB\",,,,,undefined,":{"symbol":"CHB","floatShares":210000,"roa":"--","roe":"--","lyrEps":0,"shares":210000,"dividePrice":0,"high":6.64,"amplitude":0,"preClose":6.64,"low":6.64,"week52Low":6.64,"pbRate":"--","week52High":6.64,"institutionHeld":0,"latestPrice":6.64,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":6.64,"prevYearClose":6.64,"prevWeekClose":6.64,"prevMonthClose":6.64,"prevQuarterClose":6.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CHB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-20","symbol":"CHB","reason":null,"defaultRemindTime":1708439400000,"announcedDate":"2024-02-16","type":"delisting","dateTimestamp":1708405200000},{"date":"2023-12-28","symbol":"CHB","amount":0.001878,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"Global X China Biotech Innovation ETF","recordDate":"2024-01-08","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-08"},{"date":"2023-06-29","symbol":"CHB","amount":0.037027,"announcedDate":"2023-06-28","type":"dividend","market":"US","newRecordDate":"2023-06-30","defaultRemindTime":1688045400000,"name":"Global X China Biotech Innovation ETF","recordDate":"2023-07-10","payableDate":"2023-06-30","currency":"USD","dateTimestamp":1688011200000,"payDate":"2023-07-10"},{"market":"US","date":"2022-06-29","symbol":"CHB","amount":0.019889,"defaultRemindTime":1656509400000,"name":"Global X China Biotech Innovation ETF","recordDate":"2022-07-08","payableDate":"2022-06-30","currency":"USD","type":"dividend","dateTimestamp":1656475200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CHB\",market:\"US\",,,undefined,":[{"executeDate":"2022-06-29","recordDate":"2022-06-30","paymentDate":"2022-07-08","value":0.019889,"currency":"USD"},{"executeDate":"2023-06-29","recordDate":"2023-06-30","paymentDate":"2023-07-10","value":0.037027,"currency":"USD"},{"executeDate":"2023-12-28","recordDate":"2023-12-29","paymentDate":"2024-01-08","value":0.001878,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CHB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CHB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560929367","title":"抗体浪潮风起,这家Biotech紧抓机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2560929367","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560929367?lang=zh_cn&edition=fundamental","pubTime":"2025-08-17 06:24","pubTimestamp":1755383098,"startTime":"0","endTime":"0","summary":"Vir Biotechnology不得不忙起来。7月,这家Biotech启动了第四款抗肿瘤候选药物的临床研究,尽管作为核心管线慢性丁型肝炎疗法tobevibart,相关III期试验也处于患者招募阶段。不过,相较Biotech间的联合,Vir一以贯之选择“大树好乘凉”。2025年以来,Vir的股价跌幅超过40%。VIR-5500和VIR-5818均处于积极剂量递增阶段,Vir每三周对VIR-5818进行一次剂量研究。7月31日,Vir又为ECLIPSE 2招募到首位患者。值得注意的是,Vir还把tobevibart与elebsiran的大中华区权益授予腾盛博药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817062744a48cdf2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817062744a48cdf2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4535","BK4018","BK4568","BK4548","BK4504","BNTX","BK4139","CHD","LU1585245621.USD","LU1430594728.SGD","BK4551","CHB","BK4585"],"gpt_icon":0},{"id":"2543614187","title":"股海导航_2025年6月16日_沪深股市公告与交易提示","url":"https://stock-news.laohu8.com/highlight/detail?id=2543614187","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543614187?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 07:07","pubTimestamp":1750028820,"startTime":"0","endTime":"0","summary":" 永安药业晚间发布股票交易异动暨风险提示公告称,近期公司股价短期涨幅较大,已严重偏离大盘走势,存在较高的炒作风险。2025年一季度,公司处于亏损状态。 华海药业晚间公告,公司近日收到国家药监局核准签发的富马酸喹硫平缓释片的《药品注册证书》。交易完成后,公司持有上海沃典70%股权。此次中标项目系公司在核电领域的首个订单。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-06-16/doc-infafies1199709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1878469433.USD","PI","BK4141","CHB"],"gpt_icon":0},{"id":"2543961847","title":"6月16日上市公司重要公告集锦:博众精工拟4.2亿元收购上海沃典70%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2543961847","media":"证券日报","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543961847?lang=zh_cn&edition=fundamental","pubTime":"2025-06-15 21:10","pubTimestamp":1749993039,"startTime":"0","endTime":"0","summary":"6月16日上市公司重要公告集锦:博众精工拟4.2亿元收购上海沃典70%股权","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202506153430875170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1878469433.USD","BK4141","PI","CHB"],"gpt_icon":0},{"id":"2543841618","title":"2025年6月16日涨停板早知道:七大利好有望发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=2543841618","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543841618?lang=zh_cn&edition=fundamental","pubTime":"2025-06-15 20:08","pubTimestamp":1749989280,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 6月15日消息,有七大利好可能影响明日股市,具体为:。 华海药业晚间公告,公司近日收到国家药监局核准签发的富马酸喹硫平缓释片的《药品注册证书》。富马酸喹硫平缓释片用于治疗精神分裂症和双相情感障碍的抑郁发作。 6月14日,深交所上市公司安徽安利材料科技股份有限公司公示最新一期的投资者关系活动记录表。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-06-15/doc-infaefte1791150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4141","LU1878469433.USD","PI","CHB"],"gpt_icon":0},{"id":"2543690195","title":"晚间公告丨6月15日这些公告有看头","url":"https://stock-news.laohu8.com/highlight/detail?id=2543690195","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543690195?lang=zh_cn&edition=fundamental","pubTime":"2025-06-15 19:20","pubTimestamp":1749986444,"startTime":"0","endTime":"0","summary":"【品大事】永安药业:公司股价短期涨幅较大存在较高炒作风险永安药业晚间发布股票交易异动暨风险提示公告称,近期公司股价短期涨幅较大,已严重偏离大盘走势,存在较高的炒作风险。但公司基本面没有重大变化,也不存在应披露未披露的重大信息。2025年一季度,公司处于亏损状态。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202506153430859345.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202506153430859345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4141","LU1878469433.USD","PI","CHB"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}